Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Bing Wang
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
52
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Phase II Trial of Neoadjuvant Camrelizumab and Apatinib in Resectable NSCLC: 3-Year Survival Outcomes and Dynamic Circulating Tumor DNA Analyses
Number of pages: 36
Posted: 13 Aug 2025
Wei Guo
,
liang zhao
,
Xiaowei Chen
,
Shuhang Wang
,
Xiuli Tao
,
Lin Li
,
Qianqian Sun
,
Yushun Gao
,
Yousheng Mao
,
Kang Shao
,
Fang Lv
,
Liangze Zhang
,
Wendong Liu
,
Dali Wang
,
Zhishan Li
,
Kai Su
, Bing Wang,
Feiyue Feng
,
Xinjie Chen
,
Ning Wu
,
Jianming Ying
,
Qi Xue
,
Ning Li
,
Jun Zhao
,
Fengwei Tan
and
Shugeng Gao
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Tianjin Medical University - National Clinical Research Center for Cancer, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chinese Academy of Medical Sciences - National Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Clinical Trial Center, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Thoracic Surgery
Downloads
52
(1,041,696)
View PDF
Download
Abstract:
non-small-cell lung cancer, neoadjuvant, camrelizumab, apatinib, survival
Feedback
